Clinical Applications of Nuclear Medicine Targeted Therapy

<p>THYROID DISEASES.- Diagnosis and treatment of hyperthyroidism&nbsp;(Endocrinologist).- Radiopharmaceuticals for therapy of thyroid diseases ( chemistry, mechanism of uptake, biodistribution, doses)&nbsp;&nbsp;(Radiochemist).- Radioiodine therapy of hyperthyroidism (indications , procedures and results)&nbsp;( Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).- Clinical management of thyroid cancer&nbsp;(Oncologist).- Radioidine therapy of thyroid cancer (ablation, loco-regional and distant metastases, indications&nbsp;procedures and results)&nbsp;(Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).- Novel approaches of radiometabolic treatment of thyroid cancer (Nucl Medicine Physician).- Published guidelines on radioisotopic treatments of thyroid diseases&nbsp;(Nucl Medicine Physician and Oncologist).-&nbsp;HEPATIC CANCER.- Clinical options&nbsp; for treatment of hepatocellular carcinoma (HCC)&nbsp;(Oncologist, Surge</p>on).- Radiopharmaceuticals for radioembolization&nbsp; (characteristics, mechanism of uptake,&nbsp;&nbsp; biodistribution, doses)&nbsp;(Radiochemist).- HCC radioembolization with&nbsp;⁹⁰Y microspheres (indications and procedures)&nbsp;(Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).- The clinical problem of hepatic metastases&nbsp;(Oncologist, Surgeon).- Radioembolization of hepatic metastases with&nbsp;⁹⁰Y microspheres (indications and procedures)&nbsp;(Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).- Published guidelines on radioisotope treatment of hepatocellular cancer&nbsp;(Nucl Medicine Physician and Oncologist).-&nbsp;NEUROENDOCRINE TUMORS.- Radiopharmaceuticals for treatment of neuroendocrine tumors (mechanisn of action, biodistribution, doses)&nbsp;(Radiochemis inPaediatric tumors of neuroendocrine origin&nbsp;(Oncologist).- Treatment with&nbsp;¹³¹I – MIBG (indications procedures and results)&nbsp;(Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).-&nbsp;GEP neuroendocrine tumors&nbsp;(Oncologist).- PPRT with&nbsp;⁹⁰Y labeled peptides&nbsp; (indications ,procedures and results)&nbsp;(Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).- Published guidelines on radioisotope treatment of Neuroendocrine tumors(Nucl Medicine Physician and Oncologist).-&nbsp;LYMPHOMAS.- Selection of lymphoma patients candidates for Radioimmunotherapy&nbsp;(Haematologist).- Radiopharmaceuticals for treatment of neuroendocrine tumors (mechanisn of action, biodistribution, doses)&nbsp;(Radiochemist).- Treatment with anti-CD20 Antibodies (&nbsp;⁹⁰Y- ibritumomab /¹³¹&nbsp;I- Tositumomab) (indications and procedures&nbsp; and results)&nbsp;(Nucl Medicine Physician).- Radioimmunotherapy at high doses of lymphomas&nbsp;(Nucl Medicine Physician).- Published guidelines on radioisotope treatment of Lymphomas&nbsp;(Nucl Medicine Physician and Oncologist).-&nbsp;PROSTATE CANCER.- Overview on bone metastases from prostate cancer&nbsp;(Urologist, Oncologist).-&nbsp;Radiopharmaceuticals for treatment of bone metastases (mechanisn of action, biodistribution, doses)&nbsp;(Radiochemist).- Targeted therapy with&nbsp;²²³Ra dichloride of bone metastases(Nucl Medicine Physician).- Novel approaches of treatment with&nbsp;²²³Ra based targeted therapy (Nucl Medicine Physician).- Dosimetry&nbsp;(Physicist).- Published guidelines on radioisotope treatment of Bone Metastases&nbsp;(Nucl Medicine Physician and Oncologist).<p></p>